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Thymus-derived naturally occurring regulatory T
(nTreg) cells are necessary for immunological self-
tolerance. nTreg cell development is instructed by
the T cell receptor and can be induced by agonist
antigens that trigger T cell-negative selection. How
T cell deletion is regulated so that nTreg cells are
generated is unclear. Here we showed that trans-
forming growth factor-b (TGF-b) signaling protected
nTreg cells and antigen-stimulated conventional
T cells from apoptosis. Enhanced apoptosis of
TGF-b receptor-deficient nTreg cells was associated
with high expression of proapoptotic proteins Bim,
Bax, and Bak and low expression of the antiapop-
totic protein Bcl-2. Ablation of Bim in mice corrected
the Treg cell development and homeostasis defects.
Our results suggest that nTreg cell commitment is
independent of TGF-b signaling. Instead, TGF-b
promotes nTreg cell survival by antagonizing T cell
negative selection. These findings reveal a critical
function for TGF-b in control of autoreactive T cell
fates with important implications for understanding
T cell self-tolerance mechanisms.
INTRODUCTION
The stochastic process by which T cell antigen receptors (TCRs)
are generated produces T cells bearing TCRs with high affinity
for self-antigens. Both cell-intrinsic and cell-extrinsic mecha-
nisms have evolved to control pathogenic autoreactive T cells.
T cells encountering high-affinity self-antigens in the thymus
can be eliminated through apoptosis (negative selection), which
is mediated in part by the proapoptotic molecule Bim (Bouillet
et al., 2002; Hogquist et al., 2005; Mathis and Benoist, 2004;
Palmer, 2003). In addition, regulatory T (Treg) cells expressing
the transcription factor Foxp3 are required to keep in check
the autoreactive T cells that evade negative selection (Feuerer
et al., 2009; Josefowicz and Rudensky, 2009; Sakaguchi et al.,
2008; Shevach, 2009).
Thymic differentiation of naturally occurring CD4+Foxp3+ Treg
(nTreg) cells is regulated by TCR affinity. Studies with TCR
transgenic mouse models reveal that engagement of agonist642 Immunity 32, 642–653, May 28, 2010 ª2010 Elsevier Inc.self-peptides induces not only T cell negative selection but
also nTreg cell differentiation (Apostolou et al., 2002; Jordan
et al., 2001; Kawahata et al., 2002; Walker et al., 2003). The
mechanisms by which nTreg cells are protected from clonal
deletion are unclear. nTreg cells or their precursors might be
inherently more resistant to negative selection than conventional
T cells (van Santen et al., 2004). The magnitude of clonal deletion
may also be regulated so that large numbers of nTreg cells are
produced to suppress autoreactive T cells. How TCR signaling
is integrated to the differentiation program of nTreg cells, which
culminates in the stable expression of Foxp3, also remains
incompletely understood. However, additional signals from cos-
timulatory receptors such as CD28 and cytokines including
the common g-chain cytokines appear essential for the lineage
commitment of nTreg cells (Burchill et al., 2007; Fontenot
et al., 2005; Malek et al., 2002; Salomon et al., 2000; Tai et al.,
2005; Vang et al., 2008).
Transforming growth factor-b (TGF-b) is a regulatory cytokine
with pleiotropic functions in control of T cell responses (Li and
Flavell, 2008). TGF-b1-deficient mice or mice with T cell-specific
deletion of TGF-b receptors develop early fatal multifocal inflam-
matory diseases, highlighting a pivotal role for TGF-b in T cell
tolerance. How TGF-b regulates T cell tolerance and its interac-
tions with other self-tolerance pathways including T cell-nega-
tive selection and Treg cell-mediated suppression have yet
to be clarified. Activation of naive T cells in the presence of
TGF-b induces Foxp3 expression and the differentiation of
induced Treg (iTreg) cells (Chen et al., 2003; Kretschmer et al.,
2005; Zheng et al., 2004). In contrast to the thymic origin of nTreg
cells, iTreg cells are differentiated in the periphery, and they may
control immune tolerance to innocuous environmental antigens
such as those derived from commensal flora (Curotto de Lafaille
and Lafaille, 2009). TGF-b-induced iTreg cell differentiation is in
part mediated by the recruitment of its downstream transcription
factor Smad3 to a Foxp3 enhancer element and the consequent
induction of Foxp3 gene expression (Tone et al., 2008).
The function of and mechanism by which TGF-b controls
nTreg cell differentiation and homeostasis remain ill-defined.
Studies with mice with T cell-specific deletion of the TGF-b
type II receptor (Tgfbr2) gene showed that TGF-b signaling is dis-
pensable for the development of nTreg cells in 12- to 16-day-old
mice (Li et al., 2006; Marie et al., 2006). A recent report, however,
revealed an earlier requirement for TGF-b signaling in nTreg cell
development. Conditional deletion of the TGF-b type I receptor
(Tgfbr1) gene in T cells blocks thymic nTreg cell differentiation
in 3- to 5-day-old mice but triggers nTreg cell expansion in
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TGF-b signaling was required for the induction of Foxp3 gene
expression and nTreg cell lineage commitment in neonatal
mice similar to iTreg cells (Liu et al., 2008). The later expansion,
a phenomenon also observed in mice deficient in TGF-bRII, was
explained by the enhanced nTreg cell proliferation in response to
increasing amounts of the cytokine interleukin-2 (IL-2) (Li et al.,
2006; Liu et al., 2008). Despite uncompromised thymic produc-
tion of nTreg cells in 12- to 16-day-old TGF-b receptor-deficient
mice, Treg cells are reduced in the peripheral lymphoid organs of
these mice, concomitant with the induction of rampant inflam-
matory diseases (Li et al., 2006; Liu et al., 2008; Marie et al.,
2006). The mechanisms by which TGF-b maintains peripheral
Treg cells remain to be determined.
In this study, with a T cell-specific TGF-bRII-deficient mouse
model, we found that TGF-b signaling protected thymocytes
from negative selection. In addition, TGF-b signaling inhibited
nTreg cell apoptosis that was associated with imbalanced
expression of anti- and proapoptotic Bcl-2 family proteins.
Genetic ablation of the proapoptotic molecule Bim rescued
nTreg cell death and restored the number of thymic nTreg cells
in TGF-bRII-deficient mice. Bim deficiency also corrected the
Treg cell homeostasis defects, attenuated T cell activation and
differentiation, and prolonged the lifespan of TGF-bRII-deficient
mice. These observations revealed a crucial function for TGF-b in
inhibiting T cell-negative selection and nTreg cell apoptosis. This
function was discrete from TGF-b induction of Foxp3 expression
and iTreg cell differentiation. These findings also showed that
T cell TGF-b signaling was essential for the survival of peripheral
Treg cells and for the inhibition of autoreactive T cells. Collec-
tively, our results demonstrate that TGF-b hinders deletional
tolerance but promotes immune suppression to control T cell
autoreactivity.
RESULTS
Enhanced Anti-CD3-Induced T Cell Apoptosis
in the Absence of TGF-b Signaling
Among the numerous properties of TGF-b in the immune system
is its ability to control T cell tolerance (Li and Flavell, 2008). We
sought to investigate how T cell responses to high-affinity self-
antigens are modulated by TGF-b signaling transduced by
TGF-bRI and TGF-bRII receptors. To determine whether TGF-b
receptor expression is regulated during T cell development, we
examinedmRNA expression in immature CD4+CD8+ andmature
TCR-bhiCD4+ and TCR-bhiCD8+ thymocytes. mRNA encoding
the ligand-binding receptor TGF-bRII, but not TGF-bRI, showed
approximately 5-fold higher expression in mature T cells than in
immature T cells (Figure 1A and data not shown), which was
associated with the enhanced TGF-bRII protein expression
(Figure 1B; Figure S1A available online). These observations sug-
gested that TGF-bRII-dependent signaling might regulate T cell
selection.
Thymocytes bearing high-affinity TCRs for self-antigens
undergo clonal deletion or negative selection, which provides
an important mechanism for the prevention of autoimmunity
(Hogquist et al., 2005; Mathis and Benoist, 2004; Palmer,
2003). To determinewhether TGF-bRII is required for clonal dele-
tion, we used a T cell-specific TGF-bRII-deficient (Tgfbr2/)mouse model generated by crossing a strain of floxed Tgfbr2
mice with the CD4-Cre transgene (Li et al., 2006). With these
mice, we and others have shown that TGF-bRII-dependent
signaling is essential for the maintenance of T cell tolerance
(Li et al., 2006; Marie et al., 2006), but the underlying mecha-
nisms remain elusive. Neonatal 4-day-old wild-type (Tgfbr2+/+)
and Tgfbr2/ mice were injected with either PBS or CD3 anti-
body to model high-affinity TCR ligation. 24 hr later, thymi
from these mice were collected, and the immature and mature
T cells were enumerated. As expected, T cell numbers from
Tgfbr2/ and Tgfbr2+/+ mice in the PBS control group were
comparable with the exception of a 50% reduction of
TCR-bhiCD8+ T cells in Tgfbr2/ mice as previously reported
(Figure 1C; Li et al., 2006). Surprisingly, thymocytes, notably
TCR-bhiCD4+ and TCR-bhiCD8+ mature T cell subsets, were
more profoundly depleted in Tgfbr2/ mice administrated with
CD3 antibody (Figure 1C). Enhanced T cell deletion was associ-
ated with a 3-fold increase in the size of apoptotic areas in tissue
sections from the thymi of Tgfbr2/ mice detected by TUNEL
staining (Figure 1D). Therefore, intact TGF-b signaling appeared
to be required to protect T cells from anti-CD3-induced T cell
apoptosis.
Most peripheral T cells from 4-day-old Tgfbr2/ mice mani-
fested a naive CD44loCD62Lhi phenotype similar to T cells from
Tgfbr2+/+ mice (data not shown). However, CD3 antibody might
activate these T cells and trigger the release of proinflammatory
cytokines and stress hormone that could obscure TCR-induced
deletion of thymocytes (Brewer et al., 2002). To avoid the poten-
tial complication of peripheral T cells, we isolated thymocytes
from Tgfbr2/ and Tgfbr2+/+ mice and cultured them with CD3
and CD28 antibodies for 24 hr. Subsequently, apoptotic cells
in culture were assessed with annexin V staining. Compared to
T cells from Tgfbr2+/+ mice, increased apoptosis was observed
in TCR-bhiCD4+ and TCR-bhiCD8+ T cells from Tgfbr2/ mice
(Figures S1B and S1C). These observations supported a direct
role for TGF-b signaling in inhibiting anti-CD3-induced T cell
apoptosis.
Exaggerated T Cell Negative Selection in the Absence
of TGF-b Signaling
To determine a definitive function for TGF-b in control of antigen-
induced T cell negative selection, we used a TCR transgenic
mouse model. OT-II (CD4+ TCR specific for an ovalbumin
peptide) transgenic mice were crossed to the RIP-mOVA trans-
gene driving expression of a membrane-bound form of oval-
bumin (mOVA) under the control of a rat insulin promoter (RIP)
(Kurts et al., 1996). In addition to mOVA expression in the
pancreatic b cells, mOVA is expressed in the medullary thymic
epithelial cells, leading to a pronounced thymic deletion of
OT-II T cells (Anderson et al., 2005; Gallegos and Bevan,
2004). OT-II mice were further crossed onto Rag1/ back-
ground to prevent the rearrangement of endogenous TCR that
may alter T cell antigen specificity.
In line with our previous observations (Li et al., 2006), TGF-bRII
deficiency did not affect OT-II T cell positive selection in the
absence of mOVA expression (Figures 2A and 2B). However,
thymic deletion of TCR-bhi OT-II T cells was markedly enhanced
in 5-week-old Tgfbr2/ mice on RIP-mOVA background (Fig-
ure 2A), which was associated with a profound reduction ofImmunity 32, 642–653, May 28, 2010 ª2010 Elsevier Inc. 643
Figure 1. Enhanced Anti-CD3-Induced T
Cell Apoptosis in TGF-bRII-Deficient Mice
(A and B) TGF-bRII expression in CD4+CD8+
double-positive (DP), CD4+CD8 single-positive
(CD4+SP), and CD4CD8+ (CD8+SP) thymocytes
was determined by quantitative PCR (A) and flow
cytometric analysis (B). ISC stands for isotype
control.
(C and D) Four-day-old wild-type (Tgfbr2+/+) and
TGF-bRII-deficient (Tgfbr2/) mice were intraperi-
toneally injected with PBS or 20 mg/mouse of
anti-CD3. Cell numbers of DP, CD4+SP, and
CD8+SP thymocytes were determined 24 hr after
the injection (C, n = 6). Thymocyte apoptosis was
examined by TUNEL staining 48 hr after the injection
(D, left, originalmagnification, 203). TUNELstaining-
positive area of four sections per group was quanti-
fied by MetaMorph software (D, right). Data are
representative of two (A) and three (B–D) indepen-
dent experiments. The p values between the groups
are shown. Asterisk depicts significant difference.
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RIP-mOVA mice started to develop diabetes at 6 weeks of age
(see below). It was possible that T cell negative selection may
be affected by diabetes-induced stress in week-old mice. To
minimize this effect, we determined T cell deletion in 8-day-old
mice. Diminished TCR-bhi and mature CD69CD62L+ OT-II
T cells were similarly observed in Tgfbr2/ RIP-mOVA mice
(Figure S2A). To directly assess T cell survival potential, thymic
TCR-bhi OT-II T cells were isolated from Tgfbr2/ and Tgfbr2+/+
RIP-mOVA mice by FACS sorting and cultured in medium for
12 hr. Compared to Tgfbr2+/+ OT-II T cells, approximately 50%
viable Tgfbr2/ OT-II T cells were recovered (Figure 2C). Taken
together, these findings revealed an unexpected function for
TGF-b signaling in protecting T cells from antigen-induced
negative selection.644 Immunity 32, 642–653, May 28, 2010 ª2010 Elsevier Inc.TGF-b Control of Peripheral T Cell
Tolerance to a Neo-self Antigen
Mice with T cell-specific deletion of TGF-b
receptors develop fatal systemic inflam-
matory diseases on a polyclonal T cell
background, which is associated with
widespread T cell activation (Li et al.,
2006; Liu et al., 2008; Marie et al., 2006).
However, studies with TCR-transgenic
mouse models reveal that most TGF-b
receptor-deficient T cells specific for
foreign antigens exhibit a naive T cell
phenotype (Li et al., 2006; Marie et al.,
2006). We wished to investigate whether
cognate antigen stimulation was required
for T cell hyperactivation in the absence
of TGF-b signaling. To this end, we first
determined whether TGF-bRII deficiency
would affect T cell tolerance in OT-II
RIP-mOVAmice. Consistent with previous
reports (Anderson et al., 2005; Gallegos
and Bevan, 2004), wild-type OT-II
RIP-mOVAmicewere tolerized to the oval-bumin antigen and remained diabetes free for at least 8 months
(Figure 3A and data not shown). In striking contrast, 6-week-old
Tgfbr2/ OT-II RIP-mOVA mice started to develop diabetes,
and all mice became diabetic by 10 weeks of age (Figure 3A).
Histological analysis of tissue sections from TGF-bRII-deficient,
but not wild-type, OT-II RIP-mOVA mice revealed an aggressive
leukocyte infiltrate in the islets of the pancreas (Figure 3B). In line
with these observations, TGF-bRII-deficient but not wild-type
OT-II T cells isolated from thepancreaticdraining lymphnodesdis-
played an activated CD44hiCD62Llo phenotype (Figure 3C).
However, most Tgfbr2/ OT-II T cells from the nonpancreatic
draining lymph nodes of RIP-mOVA mice, which presumably had
not been exposed to mOVA antigen, exhibited a CD44loCD62Lhi
naive T cell phenotype (Figure 3C). These observations demon-
strated that despite enhanced T cell-negative selection in the
Figure 2. Exaggerated T Cell Negative
Selection in the Absence of TGF-b Signaling
(A) Flow cytometric analysis of TCR-b expression
in thymic OT-II T cells from 5-week-old Tgfbr2+/+
and Tgfbr2/ OT-II mice in the absence or pres-
ence of RIP-mOva transgene (left). The numbers
of thymic TCR-bhi OT-II T cells from eight groups
of mice are shown (right).
(B) Flow cytometric analysis of CD69 and CD62L
expression in thymic TCR-bhi OT-II T cells from
5-week-old Tgfbr2+/+ and Tgfbr2/ OT-II mice in
the absence or presence of RIP-mOva transgene
(left). The numbers of thymic TCR-bhiCD69
CD62L+ OT-II T cells from eight groups of mice
are shown (right).
(C) Survival of thymic OT-II T cells from Tgfbr2+/+
and Tgfbr2/ mice. Thymic TCR-bhi OT-II T cells
were purified by FACS sorting and cultured for
12 hr. T cell viability before and after the cell
culture was determined by annexin V staining
(left). Percentages of viable T cells at 12 hr from
four pairs of mice are presented (right). The
p values between the groups are shown. Asterisk
depicts significant difference.
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essential for the inhibition of antigen-induced T cell activation
and for the maintenance of peripheral T cell tolerance.
Increased Thymic nTreg Cell Death in the Absence
of TGF-b Signaling
In addition to T cell negative selection, thymic generation of nTreg
cells is essential for the establishment of immunological self-toler-
ance (Feuerer et al., 2009; JosefowiczandRudensky, 2009;Saka-
guchi et al., 2008; Shevach, 2009). Using TCR transgenic mice
that express the cognate antigens in the thymus, it has been
shown that nTreg cells can be generated in response to TCR
agonist ligand stimulation (Apostolou et al., 2002; Jordan et al.,
2001; Kawahata et al., 2002; Walker et al., 2003). To investigate
whether TGF-b signaling regulates nTreg cell differentiation, we
determined the frequency and number of thymic nTreg cells in
OT-II mice. In the absence of mOVA, nTreg cells were barely
detectable in either Tgfbr2+/+ or Tgfbr2/ OT-II mice (Figure 4A;
Figure S2B). On the RIP-mOVA background, 1%–5% TCR-bhi
OT-II T cells differentiated into Foxp3+ nTreg cells in Tgfbr2+/+
andTgfbr2/mice (Figure4A; FigureS2B).However, as a conse-
quence of enhanced mOVA antigen-induced T cell deletion
(Figure 2), the numbers of both Foxp3+ nTreg cells and Foxp3
mature T cells from Tgfbr2/ mice were reduced to approxi-
mately 25% of those from Tgfbr2+/+ mice (Figure 4A and data
not shown). A recent study showed that nTreg cell development
is compromised in neonatalmicewitha T cell-specific inactivation
of TGF-bRI, which was postulated to be caused by defectiveImmunity 32, 642–6Foxp3 induction (Liu et al., 2008). Because
we observed similar frequencies of nTreg
cells in Tgfbr2/ and Tgfbr2+/+ OT-II
RIP-mOVA mice (Figure 4A; Figure S2B),
we hypothesized that nTreg cell survival,
rather than its lineage commitment, was
dependent on TGF-b signaling.We tested this hypothesis by using Tgfbr2+/+ and Tgfbr2/
mice on a polyclonal T cell background. Consistent with the
previous report (Liu et al., 2008), the number of thymic nTreg
cells in 3- to 5-day-old Tgfbr2/ mice was about 25% of that
in Tgfbr2+/+ mice (Figure 4B). The numbers of TCR-bhiCD4+
Foxp3 conventional T cells were comparable between
Tgfbr2/ and Tgfbr2+/+ mice (data not shown), most of which
were probably low-affinity TCR T cells that had undergone posi-
tive selection. A higher proportion of Tgfbr2/ nTreg cells ex-
pressed the cell proliferation marker Ki-67 than Tgfbr2+/+ nTreg
cells (Figure 4C), suggesting that reduction of Tgfbr2/ nTreg
cells was not caused by defective cell division. To directly assess
T cell survival potential, we purified thymic nTreg cells and
conventional TCR-bhiCD4+ T cells based on the expression of
Foxp3 marked by a red-fluorescent protein (Wan and Flavell,
2005). Whereas Tgfbr2+/+ and Tgfbr2/ conventional T cells
and Tgfbr2+/+ nTreg cells had a comparable survival rate,
5-fold more Tgfbr2/ nTreg cells underwent cell death after a
12 hr culture (Figure 4D). Reduced numbers of viable Tgfbr2/
nTreg cells were observed as early as 6 hr after in vitro culture
(Figure S3A). These observations revealed that concomitant
with TGF-b inhibition of T cell-negative selection, TGF-b signaling
promoted survival of thymic nTreg cells.
Bim Regulation of nTreg Cell Apoptosis
in TGF-bRII-Deficient Mice
We next sought to investigate the mechanisms underlying the
exaggerated cell death of Tgfbr2/ nTreg cells. Deletion of53, May 28, 2010 ª2010 Elsevier Inc. 645
Figure 3. Diabetes Development and T Cell
Activation in TGF-bRII-Deficient OT-II
RIP-mOva Mice
(A) The incidence of diabetes in Tgfbr2+/+ and
Tgfbr2/ OT-II RIP-mOva mice (n = 11).
(B) Hematoxylin and eosin staining of the pancreas
of 8-week-old Tgfbr2+/+ and Tgfbr2/ OT-II
RIP-mOva mice (original magnification, 203).
These are representative results of four mice per
group analyzed.
(C) Flow cytometric analysis of CD44 and CD62L
expression in OT-II T cells from nonpancreatic
control lymph nodes (LN) and pancreatic lymph
nodes (pLN) of 5-week-old Tgfbr2+/+ and
Tgfbr2/ OT-II mice in the absence or presence
of RIP-mOva transgene. Data are representative
of three independent experiments.
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which is mediated by the cysteine proteases, caspases (Lakhani
et al., 2006). Approximately 10-fold more Tgfbr2/ nTreg cells
exhibited high caspase activity than Tgfbr2+/+ nTreg cells isolated
from 3- to 5-day-old mice (Figure 5A), supporting an apoptotic
mechanism of cell death. As previously reported (Li et al., 2006;
Marie et al., 2006), the frequency of thymic nTreg cells in
16-day-old Tgfbr2/ mice was no less than that of the control
mice (Figure S3B). Importantly, elevated caspase activation was
also detected in nTreg cells from 16-day-old Tgfbr2/ mice
(Figure S3C). Recovery of thymic nTreg cells in these mice was
probably due to the long-lasting enhanced nTreg cell proliferation
(Figure 4C; Figure S3D). These findings demonstrated that TGF-b
signalingwasessential for inhibitingcaspaseactivationandnTreg
cell apoptosis in neonatal as well as week-old mice.
Signals from the common g-chain cytokines, including IL-2,
IL-15, and IL-7, are important regulators of T cell survival and
nTreg cell differentiation (Burchill et al., 2007; Fontenot et al.,
2005; Malek et al., 2002; Vang et al., 2008). To investigate
whether compromised survival of Tgfbr2/ nTreg cells was
due to defective signaling of IL-2, IL-15, or IL-7, we determined
thymic expression of these cytokines and the cytokine recep-
tors. With the exception of CD127 (IL-7 receptor a chain), the
amounts of CD25 (IL-2 receptor a chain), CD122 (the shared
IL-2 and IL-15 b chain), and CD132 (the common g chain) were
all elevated in Tgfbr2/ nTreg cells (Figure S4A), whereas the
amounts of IL-2, IL-7, and IL-15 mRNA were comparable in the
thymi of Tgfbr2+/+ and Tgfbr2/ mice (Figure S4B). To explore
a potential role for the reduced CD127 expression in Tgfbr2/646 Immunity 32, 642–653, May 28, 2010 ª2010 Elsevier Inc.nTreg cells, we crossed Tgfbr2/ mice
with a strain of IL-7R transgenic mice
(Park et al., 2004). However, restoration
of CD127 expression did not correct
the reduced frequency of Tgfbr2/
nTreg cells in 3- to 5-day-old mice (Fig-
ures S4C and S4D). These observations
suggested that nTreg cell apoptosis in
Tgfbr2/ mice was unlikely caused by
the compromised signaling of common
g-chain cytokines.A prominent pathway of caspase activation and induction of
apoptosis is through permeabilization of the outer mitochondrial
membrane, which is regulated by proteins of the Bcl-2 family
including both the prosurvival protein Bcl-2 and the proapoptotic
proteins such as Bim, Bak, and Bax (Bouillet et al., 2002; Rath-
mell et al., 2002; Youle and Strasser, 2008). Associated with
the enhanced caspase activation in Tgfbr2/ nTreg cells,
Bcl-2 expression was downregulated (Figure 5B), whereas the
expression of Bim, Bak, and Bax proteins was upregulated
(Figure 5C). Previous studies have established Bim as a key
regulator of T cell apoptosis during negative selection (Bouillet
et al., 2002). Indeed, Bim deficiency corrected the enhanced
OT-II T cell deletion in Tgfbr2/ RIP-mOVA mice (Figures 2A
and 2B; Figures S2C and S2D). To determine whether the
elevated Bim expression was causative of the enhanced
apoptosis of Tgfbr2/ nTreg cells, we crossed Tgfbr2/ mice
to the Bim-deficient (Bcl2l11/) background. The frequency
and number of thymic Tgfbr2/ nTreg cells from 3- to 5-day-
old mice were corrected by 80% in the absence of Bim
(Figure 5D), which was associated with decreased caspase acti-
vation (Figure 5E). It is noteworthy that Bim deficiency itself
caused a general increase of thymic nTreg cells (Figure 5D; Fig-
ure S5A), which was likely a consequence of reduced T cell
negative selection (Bouillet et al., 2002). CD28 costimulation is
essential for nTreg cell development, which is possibly through
CD28 regulation of Foxp3 gene expression (Salomon et al.,
2000; Tai et al., 2005). Importantly, Bim deletion did not rescue
the thymic nTreg cell defects in CD28-deficient mice (Fig-
ure S5B). These observations suggested that TGF-b signaling
Figure 4. TGF-b Control of Thymic nTreg Cell Survival
(A) Thymic nTreg cells from 5-week-old Tgfbr2+/+ and Tgfbr2/OT-II mice in the absence or presence of RIP-mOva transgene. Foxp3 expression in TCR-bhi OT-
II T cells (left) and the percentages (right top) and numbers (right bottom) of nTreg cells from Tgfbr2+/+ and Tgfbr2/ OT-II RIP-mOva mice are shown (n = 8).
(B) Thymic nTreg cells in 3- to 5-day-old Tgfbr2+/+ and Tgfbr2/mice. Foxp3 expression in TCR-bhiCD4+ T cells (left) and nTreg cell numbers from Tgfbr2+/+ and
Tgfbr2/ mice (right) are shown (n = 5).
(C) Flow cytometric analysis of Ki67 expression in thymic nTreg cells from 3- to 5-day-old Tgfbr2+/+ and Tgfbr2/ mice. These are representative results of four
mice per group analyzed.
(D) Thymic Foxp3+CD4+ single-positive (SP) nTreg cells and Foxp3CD4+ SP conventional T cells were purified by FACS sorting from 14- to 16-day-old Tgfbr2+/+
and Tgfbr2/mice and cultured for 12 hr. T cell viability before and after the cell culture was determined by annexin V staining (left). Percentages of viable T cells
at 12 hr from five pairs of mice are presented (right). The p values between the groups are shown. Asterisk depicts significant difference.
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dent apoptosis and was unlikely involved in the induction of
Foxp3 expression in nTreg cells.
Bim Control of Treg Cell Homeostasis
and T Cell Activation in TGF-bRII-Deficient Mice
Treg cells fail to be maintained in the peripheral lymphoid organs
of TGF-b receptor-deficient mice (Li et al., 2006; Liu et al., 2008;
Marie et al., 2006), but the underlyingmechanisms have yet to be
characterized. To determine whether Bim-dependent apoptosis
accounted for this defect, we examined peripheral Treg cells in
mice deficient in both TGF-bRII and Bim (Tgfbr2/Bcl2l11/).
Whereas the frequency of splenic and lymph node Treg cells
from Tgfbr2/ mice was lower than that from Tgfbr2+/+ mice,
an almost complete rescue of the proportion of Treg cells was
observed in Tgfbr2/Bcl2l11/ mice (Figures 6A and 6B; Fig-
ure S5C). Reduced Treg cells in Tgfbr2/mice were associated
with an approximate 2-fold increase of Treg cell apoptosis,
which was corrected by 60% in the absence of Bim (Figure 6C).
Notably, Bim deletion did not rescue the peripheral Treg cell
defects in CD28-deficient mice (Figure S5B). These observationsrevealed a specific function for TGF-b signaling in protecting
peripheral Treg cells from mitochondrion-dependent apoptosis.
To determine the effects of Bim deficiency on the anergic
phenotype of Treg cells and Treg cell-suppressive function, we
used CFSE-based cell proliferation assays. Whereas wild-
type or Bcl2l11/ Treg cells were refractory to anti-CD3-
induced proliferation, Tgfbr2/ and Tgfbr2/Bcl2l11/ Treg
cells underwent substantial cell division (Figure S5D). Compared
to wild-type Treg cells, Tgfbr2/ Treg cells had enhanced
suppressive activity on a per cell basis, whereas Bcl2l11/
Treg cells were less suppressive (Figure 6D). Importantly,
Tgfbr2/Bcl2l11/ Treg cells had comparably suppressive
activity to wild-type Treg cells (Figure 6D). To investigate the
impact of Bim deficiency on peripheral T cell tolerance, we
examined the lifespan of Tgfbr2/Bcl2l11/ mice. Whereas
100% Tgfbr2/ mice died by 5 weeks of age, all Tgfbr2/
Bcl2l11/ mice survived during the same period (Figure 7A).
Compared to CD4+ T cells from Tgfbr2/ mice, a smaller
proportion of CD4+ T cells from Tgfbr2/Bcl2l11/ mice
exhibited an activated CD44hiCD62Llo phenotype (Figure 7B),
and fewer CD4+ T cells produced the effector cytokine IFN-gImmunity 32, 642–653, May 28, 2010 ª2010 Elsevier Inc. 647
Figure 5. TGF-b Signaling Regulates Thymic nTreg Cell Development via the Inhibition of Bim-Dependent Apoptosis
(A) Flow cytometric analysis of caspase activation in 4-day-old thymic nTreg cells from Tgfbr2+/+ and Tgfbr2/mice. These are representative results of fourmice
per group analyzed.
(B) Flow cytometric analysis of Bcl-2 expression in thymic nTreg cells from Tgfbr2+/+ and Tgfbr2/ mice. ISC stands for the isotype control antibody.
(C) The expression of Bim, Bak, and Bax in thymic nTreg cells from Tgfbr2+/+ and Tgfbr2/ mice was determined by immunoblotting. b-actin was used as
a protein-loading control. Band densities were quantified by ImageJ. The relative protein amounts are shown. Data are representative of three independent
experiments.
(D) Restoration of thymic nTreg cell development in Tgfbr2/ mice by Bim deletion. Foxp3 expression in thymic TCR-bhiCD4+ T cells from 4-day-old Tgfbr2+/+
Bcl2l11+/+, Tgfbr2/Bcl2l11+/+, Tgfbr2+/+Bcl2l11/, and Tgfbr2/Bcl2l11/ mice (left) and nTreg cell numbers from five groups of 3- to 5-day-old mice are
presented (right). The p values between the groups are shown. Asterisk depicts significant difference.
(E) Flow cytometric analysis of caspase activation in thymic nTreg cells from Tgfbr2+/+Bcl2l11+/+, Tgfbr2/Bcl2l11+/+, Tgfbr2+/+Bcl2l11/, and Tgfbr2/
Bcl2l11/ mice. A representative of three independent experiments is shown.
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succumbed to a lethal multifocal inflammatory disorder similar
to that of Tgfbr2/ mice (Figure 7A; Figure S6). These observa-
tions revealed that Bim rescue of peripheral Treg cells was asso-
ciated with a partial correction of the T cell activation and lethal
autoimmune phenotype in Tgfbr2/ mice.
DISCUSSION
Although TGF-b has been established as a pivotal regulator of
T cell tolerance, the underlying mechanisms remain elusive. In
this report, we used a T cell-specific TGF-bRII-deficient mouse
strain to study the function of TGF-b signaling in control of
T cell-negative selection and nTreg cell development, two estab-
lished pathways of T cell self-tolerance. By using anti-CD3-
induced and antigen-triggered T cell deletion models, we found
that thymic-negative selectionwas repressed by TGF-b signaling
in T cells. TGF-b inhibition of T cell deletion promoted thymic
Treg cell survival, revealing a mechanism for TGF-b in regulation
of nTreg cell development. Enhanced apoptosis of TGF-bRII-648 Immunity 32, 642–653, May 28, 2010 ª2010 Elsevier Inc.deficient nTreg cells was associated with high expression of
the proapoptotic Bcl-2 family protein Bim, lack of which partially
rescued the nTreg cell death phenotype. In addition, we found
that TGF-bRII-deficient Treg cells in peripheral tissues under-
went exaggerated Bim-dependent apoptosis; Bim deficiency
restored peripheral Treg cells, inhibited T cell activation, and
extended the lifespan of T cell-specific TGF-bRII-deficient
mice. These observations uncover previously undefined func-
tions for TGF-b signaling in control of deletional tolerance and
Treg cell-mediated immune suppression in vivo.
Autoreactive T cells can be readily found in the peripheral
lymphoid organs of healthy individuals (Danke et al., 2004). In
animal models of T cell-negative selection, a large fraction of
T cells also escape clonal deletion (Bouneaud et al., 2000).
Lack of complete deletion of autoreactive T cellsmay be a conse-
quence of limited expression and/or presentation of self-anti-
gens in the thymus. Here we showed that negative selection
was also actively suppressed by TGF-b signaling in T cells.
Although the significance of this regulatory pathway remains
to be fully elucidated, we found that by inhibiting T cell clonal
Figure 6. Bim Ablation Restores Peripheral Treg Cells in TGF-bRII-Deficient Mice
(A and B) Flow cytometric analysis of Foxp3 expression in splenic (A) and lymph node (LN) (B) CD4+ T cells from 16-day-old Tgfbr2+/+Bcl2l11+/+, Tgfbr2/
Bcl2l11+/+, Tgfbr2+/+Bcl2l11/, and Tgfbr2/Bcl2l11/ mice (left). Treg cell percentages from eight groups of 14- to 16-day-old mice are shown (right).
(C) Splenic and lymph node Treg cells were purified from 16-day-old Tgfbr2+/+Bcl2l11+/+, Tgfbr2/Bcl2l11+/+, Tgfbr2+/+Bcl2l11/, and Tgfbr2/Bcl2l11/
mice by FACS sorting, and cultured for 12 hr. T cell viability before and after the cell culture was determined by annexin V staining (left). Percentages of viable
T cells at 12 hr from six groups of 14- to 16-day-oldmice are presented (right). The p values between the groups are shown. Asterisk depicts significant difference.
(D) Suppressive function of Tgfbr2+/+Bcl2l11+/+, Tgfbr2/Bcl2l11+/+, Tgfbr2+/+Bcl2l11/, and Tgfbr2/Bcl2l11/ Treg cells. Splenic and lymph node
Foxp3+CD4+ Treg cells were isolated from Tgfbr2+/+Bcl2l11+/+, Tgfbr2/Bcl2l11+/+, Tgfbr2+/+Bcl2l11/, and Tgfbr2/Bcl2l11/ mice. CD44loCD4+ T cells
from Tgfbr2+/+Bcl2l11+/+ mice were labeled with CFSE and used as responding T (Tresp) cells. Cell division was assessed by CFSE dilution. The percentages
of undivided Tresp cells (y axis) and the ratios of cell numbers between Treg and Tresp cells (x axis) were plotted (left). A representative of CFSE dilution of Tresp
cells cultured in the absence or presence of 1:2 ratio of Treg to Tresp cells was shown (right). These are representative of three independent experiments.
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TGF-b Control of Thymic Treg Cell Developmentdeletion, TGF-b enhanced nTreg cell production. nTreg cells
exhibit an ‘‘antigen-experienced’’ phenotype, suggesting that
their differentiation process is induced or accompanied by expo-
sure to high-affinity self-antigens (Josefowicz and Rudensky,2009; Sakaguchi et al., 2008). Recent studies of transgenic
mice expressing TCRs derived from Treg cells demonstrate
that nTreg cell differentiation is indeed instructed by TCR spec-
ificity (Bautista et al., 2009; DiPaolo and Shevach, 2009; LeungImmunity 32, 642–653, May 28, 2010 ª2010 Elsevier Inc. 649
Figure 7. Bim Ablation Partially Restores T
Cell Tolerance in TGF-bRII-Deficient Mice
(A) Survival of Tgfbr2/Bcl2l11+/+ (n = 18) and
Tgfbr2/Bcl2l11/ (n = 8) mice.
(B) Flow cytometric analysis of CD44 and CD62L
expression in splenic and lymph node (LN) CD4+
T cells from 14-day-old Tgfbr2+/+Bcl2l11+/+,
Tgfbr2/Bcl2l11+/+, Tgfbr2+/+Bcl2l11/, and
Tgfbr2/Bcl2l11/ mice. These are representa-
tive results of four mice per group analyzed.
(C) Splenic and LN CD4+ T cells from 14-day-old
Tgfbr2+/+Bcl2l11+/+, Tgfbr2/Bcl2l11+/+, Tgfbr2+/+
Bcl2l11/, and Tgfbr2/Bcl2l11/ mice were
stimulated with PMA and ionomycin for 4 hr and
analyzed for the expression of IFN-g by intracel-
lular staining. A representative of three indepen-
dent experiments is shown.
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TGF-b Control of Thymic Treg Cell Developmentet al., 2009). Intriguingly, the proportion of Treg cell-TCR trans-
genic T cells that mature into the Treg cell lineage is inversely
correlated with the precursor frequency (Bautista et al., 2009;
Leung et al., 2009), which could be explained by intraclonal
competition for limited Treg cell-selecting high-affinity self
MHC-peptide complexes. In one Treg cell-TCR transgenic
mouse strain, profound T cell deletion was observed (DiPaolo
and Shevach, 2009), revealing that at least some endogenous
nTreg cells were differentiated in response to high-affinity self-
antigens. Consistent with these and previous studies (Apostolou
et al., 2002; Jordan et al., 2001; Kawahata et al., 2002; Walker
et al., 2003), coexpression of mOVA in OT-II transgenic mice trig-
gered nTreg cell differentiation, concomitant with the induction
of T cell-negative selection. Blockade of TGF-b signaling in
OT-II T cells resulted in heightened deletion of nTreg cells as
well as conventional T cells in response to mOVA antigen. These
observations are in line with the reports that Foxp3 deficiency
does not affect the efficiency or sensitivity of T cell-negative
selection (Chen et al., 2005; Hsieh et al., 2006). Collectively,
our findings suggest that nTreg cells are not inherently more
resistant to apoptosis than conventional T cells, but the magni-
tude of T cell clonal deletion can be regulated to ensure proper
production of nTreg cells.
The Treg cell-specific transcription factor Foxp3 can be
induced in both developing thymocytes and peripheral T cells
in response to appropriate combinations of TCR, costimulatory
molecule, and cytokine stimulation (Josefowicz and Rudensky,
2009). Activation of peripheral naive CD4+ T cells in the presence
of TGF-b induces Smad-dependent Foxp3 expression and iTreg
cell differentiation. Defective nTreg cell development had also
been observed in neonatal micewith a T cell-specific inactivation
of TGF-bRI, which was postulated to be caused by failed Foxp3
induction (Liu et al., 2008). Similar neonatal nTreg cell defects
were present in TGF-bRII-deficient mice. However, we found
that compromised differentiation of TGF-bRII-deficient nTreg650 Immunity 32, 642–653, May 28, 2010 ª2010 Elsevier Inc.cells was associated with high expres-
sion of the proapoptotic molecule Bim,
enhanced caspase activation, and
increased nTreg cell apoptosis. Impor-
tantly, genetic ablation of Bim restored
nTreg cells in TGF-bRII-deficient mice. Itis noteworthy that Bim deficiency did not correct the nTreg cell
defects in mice lacking the costimulatory molecule CD28, the
signals from which probably directly control Foxp3 gene tran-
scription. These findings suggest that in contrast to iTreg cells,
TGF-b signaling is not essential for the induction of Foxp3
expression in nTreg cells, but is required to inhibit Bim-depen-
dent nTreg cell apoptosis.
The cellular and molecular mechanisms by which TGF-b regu-
lates Bim expression and nTreg cell apoptosis are open for future
studies. There are three types of TGF-b molecules in mammals,
with TGF-b1 being the major protein expressed in the immune
system (Li and Flavell, 2008). A previous report showed that
T cells from TGF-b1-deficient mice are more susceptible to
anti-CD3-induced T cell death, which was attributed to an intra-
cellular function of TGF-b1 located in the mitochondrion (Chen
et al., 2001). Because we found that TGF-bRII-deficient T cells
were also hypersensitive to anti-CD3-induced apoptosis,
TGF-b1 protection of T cell deletion was more likely mediated
by the extracellular cytokine activity of TGF-b1. Whether
TGF-b1 is involved in the inhibition of Bim expression and nTreg
cell apoptosis has yet to be determined. In addition, multiple cell
types produce TGF-b1 in vivo. By using a conditionally deficient
TGF-b1 mouse model, we have identified T cells as an essential
source of TGF-b1 for control of T cell tolerance and effector T cell
differentiation (Li et al., 2007). The functions of T cell or other cell
type-produced TGF-b1 in control of nTreg cell survival will be an
interesting topic for future study.
TGF-b engagement of the receptor complex initiates diverse
signaling pathways that enable TGF-b to exert its pleiotropic
functions (Li and Flavell, 2008). The signaling pathways involved
in TGF-b inhibition of Bim expression in nTreg cells are unknown.
Two recent reports using a transgenic mouse strain expressing
a dominant-negative mutant of TGF-bRII (DNRII) in the T cell
compartment revealed that TGF-b signaling promotes apoptosis
of pathogen-specific CD8+ effector T cells (Sanjabi et al., 2009;
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TGF-b Control of Thymic Treg Cell DevelopmentTinoco et al., 2009). In one study, decreased apoptosis of DNRII
CD8+ T cells is associated with reduced Bim expression (Tinoco
et al., 2009). It is currently unknown how TGF-b opposingly
regulates Bim expression in nTreg cells and effector CD8+
T cells. We showed previously that the DNRII model, in contrast
to the TGF-bRII conditional knockout mouse model used in this
study, affords only a partial blockade of TGF-b signaling in
T cells (Li et al., 2006), which might affect TGF-b regulation of
Bim expression and T cell survival. It is also possible that TGF-b
control of Bim expression is context dependent, with the ultimate
effectbeingdeterminedby thedevelopmental stagesofTcells and
other environmental cues received by the T cells. It is noteworthy
that Bim ablation did not completely rescue caspase activation
in TGF-bRII-deficient mice. Other Bcl-2 family proteins including
Bax, Bak, and Bcl-2 were dysregulated in TGF-bRII-deficient
nTregcells, raising thepossibility that theymight control Bim-inde-
pendent caspaseactivation.HowTGF-b regulates theseandother
alternative apoptosis pathways warrants further investigation.
Thymic nTreg cells from week-old TGF-bRII-deficient mice
were equally susceptible to apoptosis as nTreg cells from
neonatal mice. But thymic nTreg cell numbers were restored,
which could be attributed to the enhanced cell proliferation.
Nevertheless, the peripheral Treg cell numbers were reduced
in TGF-bRII-deficient mice, revealing that intact TGF-b signaling
was required for the maintenance of Treg cells. In this study, we
found that compromised Treg cell maintenance was caused
by Bim-dependent Treg cell apoptosis. Interestingly, Bim
deficiency not only restored peripheral Treg cells, but also
attenuated T cell activation and prolonged the lifespan of
TGF-bRII-deficientmice. These findings suggest that TGF-b inhi-
bition of peripheral Treg cell apoptosis contributes to themainte-
nance of T cell self-tolerance. A recent study showed that
Bim-deficient T cells are refractory to TCR-induced calcium
responses (Ludwinski et al., 2009), raising the possibility that
T cell-intrinsic defects might also contribute to the attenuated
T cell activation and differentiation phenotype in Tgfbr2/
Bcl2l11/ mice. However, Bim ablation could not completely
prevent the lethal inflammation developed in TGF-bRII-deficient
mice. These observations are in line with the findings that Treg
cells are incapable of suppressing intestinal inflammation
induced by naive CD4+ T cells resistant to TGF-b signaling
(Fahlen et al., 2005) and that transfer of wild-type Treg cells to
neonatal Tgfbr2/ mice fails to correct the systemic autoim-
mune disease (Li et al., 2006). Therefore, in addition to the
maintenance of peripheral Treg cells, TGF-b signaling is indis-
pensable for inhibiting autoreactive T cell activation and effector
T cell differentiation.
In conclusion, in this reportwehaveuncovered critical functions
for TGF-b signaling in control of T cell negative selection, Treg cell
development and homeostasis, and peripheral tolerance of autor-
eactive T cells. These findings refine and extend our under-
standingofTcell self-tolerancemechanismsandmaybeexploited
for the immunotherapy of autoimmune diseases in the future.EXPERIMENTAL PROCEDURES
Mice
Mice containing floxed Tgfbr2, CD4-Cre, OT-II, Rag1, RIP-mOva, Bcl2l11,
Il7rTg, CD28, and Foxp3-RFP alleles were previously described (Bouilletet al., 2002; Kurts et al., 1996; Li et al., 2006; Park et al., 2004; Wan and Flavell,
2005). Foxp3-RFP mice were provided by R. Flavell (Yale). RIP-mOva and
IL-7R transgenic mice were provided by W. Heath (The Walter and Eliza Hall
Institute of Medical Research) and A. Singer (National Cancer Institute),
respectively. Bcl2l11/, CD28/, and Rag1/ mice were purchased from
the Jackson Laboratory. Mice with two floxed Tgfbr2 alleles were used as
controls (Tgfbr2+/+). T cell-specific TGF-bRII-deficient mice (Tgfbr2/) were
generated by crossing Tgfbr2-floxed mice with the CD4-Cre transgene.
Tgfbr2/ and CD28/ mice were crossed with Bcl2l11/ mice to produce
mice devoid of both genes (Tgfbr2/Bcl2l11/ and CD28/Bcl2l11/).
Tgfbr2/ and Tgfbr2/Bcl2l11/ mice were crossed with Foxp3-RFP
mice to mark Treg cells by red-fluorescent protein expression. OT-II RIP-
mOva mice on a Rag1-deficient background were crossed with Tgfbr2/
mice to generate Tgfbr2/ OT-II RIP-mOva mice. Urine glucose concentra-
tions in these mice were monitored by using Diastyx sticks (Bayer) on a weekly
basis. Animals that had values of >250 mg/dl on two consecutive occasions
were counted as diabetic. All mice were maintained under specific path-
ogen-free conditions, and animal experimentation was conducted in accor-
dance with institutional guidelines.
Flow Cytometry
Fluorescent-dye-labeled antibodies against cell surface markers CD4, CD8,
TCR-b, CD69, CD62L, CD44, CTLA4, GITR, ICOS, CD27, CD25, CD122,
CD132, and CD127 were purchased from eBiosciences. Biotinylated mouse
TGF-bRII antibody was obtained from R&D Systems. Thymic, splenic, and
lymph node cells were depleted of erythrocytes by hypotonic lysis. Cells
were incubated with specific antibodies for 15 min on ice in the presence of
2.4G2 mAb to block FcgR binding. All samples were acquired and analyzed
with LSR II flow cytometer (Becton Dickinson) and FlowJo software (Tree
Star). Intracellular Foxp3, CTLA4, Ki67, and Bcl-2 stainings were carried out
with kits from eBiosciences and BD Biosciences. For intracellular cytokine
staining, spleen and lymph node cells were stimulated with 50 ng/ml phorbol
12-myristate 13-acetate (PMA, Sigma), 1 mM ionomycin (Sigma) andGolgiStop
(BD Biosciences) for 4 hr. After stimulation, cells were stained with cell surface
marker antibodies, fixed and permeabilized with a Cytofix/Cytoperm kit
(BD Biosciences), and stained with an IFN-g antibody.
Immunoblotting
Thymic Foxp3+ Treg cells marked by red-fluorescent protein expression were
purified by FACS sorting. Protein extracts were prepared, separated on 15%
SDS PAGE gels, transferred to PVDF membrane (Millipore), and probed with
antibodies against Bim (Stressgen), Bax (Upstate), Bak (Upstate), and b-actin
(Sigma).
Quantitative PCR
CD4+CD8+ double-positive (DP), TCR-bhiCD4+ single-positive (SP), and
TCR-bhiCD8+ SP thymocytes were isolated by FACS sorting and used for
RNA extraction. TGF-bRII mRNA amounts were determined by quantitative
PCR (qPCR) with the primer set: 50-atctggaaaacgtggagtcg-30 and 50-tccttca
cttctcccacagc-30. To determine the expression of common g chain cytokines,
thymus was lyzed by Trizol for RNA preparation. The amount of IL-2, IL-7, and
IL-15 was measured by qPCR with the following primer sets: 50-cccactt
caagctccacttc-30 and 50-ttcaattctgtggcctgctt-30 (IL-2), 50-atccttgttctgctgc
ctgt-30 and 50-tggttcattattcgggcaat-30 (IL-7), 50-cattttgggctgtgtcagtg-30 and
50-gcaattccaggagaaagcag-30 (IL-15). The expression of TGF-bRII, IL-2, IL-7,
and IL-15 was normalized to the b-actin amounts detected by qPCR with
the primer set: 50-ttgctgacaggatgcagaag-30 and 50-acatctgctggaaggtggac-30.
Apoptosis Assays
Foxp3+ Treg cells, conventional T cells, and OT-II T cells were purified by FACS
sorting and cultured in T cell medium (RPMI1640 medium supplemented
with 0.1 mM glutamine, 10 mM HEPES, 1 mM sodium pyruvate, 55 mM 2-mer-
captoethanol, 10U/ml penicillin, 10mg/ml streptomycin, and nonessential amino
acids) for 6 and 12 hr. Cell apoptosis was determined by staining with FITC-
labeled annexin V (BD Biosciences). To assess anti-CD3-induced thymocyte
apoptosis in vitro, total thymocytes were stimulated with plate-bound anti-CD3
and anti-CD28 for 24 hr and stained with fluorescent-dye-labeled anti-TCR-b,Immunity 32, 642–653, May 28, 2010 ª2010 Elsevier Inc. 651
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subpopulations were determined by flow cytometry.
For active caspase measurements, thymocytes were cultured in T cell
medium in the presence of 10 mM FITC-VAD-FMK (Promega) for 20 min,
washed twice with cold PBS, and stained with antibodies against cell surface
markers before subjected to flow cytometric analysis.
The TUNEL protocol with tyramide signal amplification was developed at the
Molecular Cytology Core Facility at Memorial Sloan-Kettering Cancer Center.
Four-micron tissue sections were treated with 20 mg/ml Proteinase K (Sigma)
for 15 min at 37C and fixed with 4% paraformaldehyde for 10 min at room
temperature. Blocking of endogenous peroxidases was performed for
10 min in 1%H2O2 at room temperature. TdT (terminyl deoxynucleodityl trans-
ferase, Roche)-mediated biotin-dUTP end nick labeling reaction was per-
formed at 4C overnight. Tyramide-biotin (Perkin Elmer) was used to amplify
the signal. Biotin was detected with a Vectastain ABC Kit (Vector Laborato-
ries). Peroxidase activity was determined by incubating the slides in 0.2 mg/ml
DAB in PBS with 50 ml of 30%H2O2 for 5 min at room temperature. Slides were
counterstained with Harris Hematoxylin (Fisher Scientific), dehydrated, and
mounted with Permount (Fisher Scientific). TUNEL-positive areas from four
sections were quantified with the MetaMorph software.
Treg Cell Suppression Assay
Splenic and lymph node CD4+Foxp3+ regulatory T (Treg) cells were isolated
from16-day-oldTgfbr2+/+Bcl2l11+/+, Tgfbr2/Bcl2l11+/+, Tgfbr2+/+Bcl2l11/,
and Tgfbr2/Bcl2l11/mice by FACS sorting. CD44loCD4+RFP cells sorted
from Tgfbr2+/+Bcl2l11+/+ mice were labeled with 4 mM of carboxyfluorescein
diacetate succinimidyl ester (CFSE, Sigma) at 37C for 10 min and used as
responder T (Tresp) cells. 5 3 104 Tresp cells were cultured in 96-well plates
with 105 irradiated splenocytes and 2 mg/ml CD3 antibody in the presence of
different numbers of Treg cells for 72 hr.
Histopathology
Tissues from sacrificed animals were fixed in Safefix II (Protocol) and
embedded in paraffin. 5 mmsections were stained with hematoxylin and eosin.
Statistical Analysis
Student’s t test was used to calculate statistical significance for difference in
a particular measurement between groups. A p value of <0.05 was considered
statistically significant.
SUPPLEMENTAL INFORMATION
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